Showing results (521-530 of 1,794) with videos related to

Sort By:
Pageof 180
Mabs|August 30, 2019
Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and developmentRomain Ollier, Paul Wassmann, Thierry Monney, et al.
Mabs|September 15, 2022
Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary namesIan Wilkinson, Geoff Hale
Mabs|October 6, 2022
Fast-tracking antibody maturation using a B cell-based display systemHitomi Masuda, Atsushi Sawada, Shu-Ichi Hashimoto, et al.
Mabs|March 5, 2021
Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2Shion A Lim, Josef A Gramespacher, Katarina Pance, et al.
Mabs|August 29, 2025
Combining deep mutational scanning and SPR binning approaches for large-scale epitope identification of anti-ricin antibodiesOphélie Kot, Lois Lequesne, Hans Werner Mages, et al.
Mabs|September 1, 2025
A bispecific antibody-drug conjugate targeting CD7 and CD33 shows anti-tumor activity and improved tumor selectivity in an aggressive subtype of acute myeloid leukemiaHollie B S Griffiths, Nyle Jones, Mattia Vitale, et al.
Mabs|June 18, 2015
A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cellsEmily C Piccione, Silvia Juarez, Jie Liu, et al.
Mabs|June 4, 2020
Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodiesAmita Datta-Mannan, Selina Estwick, Chen Zhou, et al.
Mabs|August 12, 2021
An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeuticsNorbert Furtmann, Marion Schneider, Nadja Spindler, et al.
Mabs|August 4, 2021
Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft modelParul Gupta, Ziyue Karen Jiang, Bing Yang, et al.
Pageof 180